Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Filings? Gee. I never thought to look there. Thanks
I found my own info plus some other tidbits.
Sorry to say In my opinion It's not pretty
Still holding some shares. We will see
Recommend every one do a little mathematics and come to your own conclusions.
So Long for now
Good luck to all
Anyone know where I can find how many Preferred A shares are outstanding which are going to convert into ordinary shares at 100,000 to 1 ?
If all warrants are exercised and notes converted it will result in 654 million more ordinary shares. That will put Todos at 1.85 billion outstanding ordinary shares before any preferred shares are converted.
Not easy to talk about but important if one tries to put an estimate of what their investment is truly worth.
So does anyone know how many Preferred A shares are issued.
Thank You
I am wondering about how high the outstanding ordinary share count will grow.
Does anyone know how many Preferred A shares are issued?
I found this but am confused by it
Authorized Share Capital. The authorized share capital of the Company is as follows:
(a)
NIS 100,000,000, consisting of 10,000,000,000 Ordinary Shares par value NIS 0.01 each;
(b)
NIS 500 consisting of 50,000 Preferred A Shares par value NIS 0.01 each; and
(c)
NIS 50 consisting of 5,000 Preferred B Shares par value NIS 0.01 each.
Thank you
Doctor,
I am giving it plenty of time.
Have been into this since spring of 2021.
Not as long as some others here though .lol
.
I have never seen any company receive such disrespect from the market. Watching other OTC tickers skyrocket on BS news while they have no real product, revenues or plans is disheartening.
We should be substantially higher than the current SP
I've said it before and I'll say it again.
I think it is going to take a HUGE announcement on the NATIONAL level before this starts to move.
Sad but true
I would be thrilled if the market would allow share price to reflect the true valuation of Todos. Problem is TOMDF is getting clumped together with all other OTC stocks, most of which have no real business, no products, no revenues etc etc. So what happens. The penny pinching day traders jump in on any good news, and then sell taking a quick hit profit, which does not let the SP get a good footing.
I am expecting a rock solid quarterly tomorrow, which in the real world would propel the SP. But probably will have little effect here in OTCQ land.
I think it is going to take a blockbuster announcement, such as an EUA which is broadcast on the national level before we will gain traction.
And here's to hoping GC holds off until then to apply for an R/S and uplist.
AMHO
I have been invested in and following the Todos story for well over a year now. In all of my years I have never seen a ticker with more promise than this one. The lack of share price support is almost unimaginable.
It's disheartening to see OTC or pink sheet symbols that have no real products or any revenues trading higher and have a higher market cap than a company like Todos with proven testing, revenues,,drugs in the pipeline, accomplished doctors on board etc etc etc.
This SP is just being manipulated by market makers, day traders and toxic note
holders.
I truly feel that shortly the day will come when all longs, who have stood with Tomdf all this time, will receive their just rewards.
No need to reply. I am just venting to myself.
The flippers will flip, the daytraders will trade. Thay are not interested in the big story or the potential that we have.
When this finally takes off on the anticipated quarterly and EUA application they will make the volatility of the share price insane.
I will be holding fast focused on the true potential, not settling or guessing when to buy or sell for peanuts.
One bit of news and all the daytraders show up lol. If only they knew the real possibilities of TOMDF they wouldn't trade for pennies. (Or tenths of a penny)
I am not on twitter.
I would greatly appreciate it if someone who is please ask GC why the increase from 1/500 to 1/1000 and is he still standing by his prior words to not R/S at such an anemic share price.
I cant think of any other reason why to ask for the increase unless the R/S is ocurring at any price.
Thank you
Stu and Grease.
I remember also the no split at these levels talk. However I worry that the mindset of GC and the company has changed, The authorization to R/S that was given by shareholders was for a range of 1/2 up to 1/500. (it expired three days ago)
This new prospectus will only be offered if the stock is uplisted and in August the company is going to ask the shareholders to approve an R/S in the range of 1/2 up to 1/1000.
So, if GC said he would never R/S at such a low share price, then why ask for an increase in the maximum size of the R/S from 1/500 to 1/1000? Anyone?
. If this is done, we as shareholders are finished. GC needs to remember that as a CEO his first obligation is to act in a manner that will benefit CURRENT shareholders. If he does go through with a massive split at low levels it will show that he has punted and is giving us up. And, YES, you are both right, it will be another AMBS.
I hope he stands by his word and his obligation to us.
I believe there has to be an R/S first
Not really important but just realized that the shareholders approval for an R/S expires today, 7/26/2022.
Figuring there will be another vote by shareholders to approve one in the future, if the company ever gets to that point.
Drey,
"not taking the recommended dosing or frequency" could be a summation of why Tollovid didnt work for you. The frequency and dosage ARE what makes any medication perform as expected in the body. Antibiotics are only useful in killing say, a strep throat, if taken as prescribed. Not keeping the amount of antibiotic at the proper level in the body will either result in not curing the strep or taking much longer to kill it.
I would have to surmise that Tollovid, although not a medication, works exactly the same way. I am sure Dr. Arad knows what she is doing when setting the dosage requirements.
I, too, am underwater at this point. I am as frustrated as anyone at the amount of time this is taking, but penny stocks don't have the unlimited resources the big players have so I try to understand and put that fact into the equation.
I am holding fast with the belief that in the long scenario the science will prevail and so will Todos. If you have lost all hope then it probably would be best to sell and put this in your rearview mirror. I just dont see the sense of holding while ripping the company. Kinda like rooting for your team to lose the game because you are frustrated with the quarterback..
All in my opinion.
Good day to you.
Todos did not "miss the boat" on active cases.
Active cases are going to be skyrocketing the next few weeks. The number of people with Covid who are self testing and not reporting are not being counted in the current published totals.
With the expected onslaught of BA 5 the time is perfect to be submitting an EUA for Tollovir for active infection and /or Tollovid for long covid.
We are all frustrated with how long this has taken. I have been into Todos for well over a year now. I actually walked away once or twice due to misplaced anger due to my thinking nothing was happening fast enough. (which you refer to as kicking the can)
Zero shares being issued in last 4 months. Has to make one believe the 10Q will show a huge increase in revenues. EUA finally a real possibility. For me, too much good news not to be in it. After waiting all this time. if this does takeoff, I would kick myself for not finally reaping some reward, because I do believe in the science behind 3CL inhibitors.
To each his own.
All in my own opinion
Wouldn't it be great to have a pill that will stop Covid's replication in the human body.. Paxlovid will work but it must be taken in the first 5 days and I personally know 3 people currently with Covid that cannot take it due to pre existing conditions. (All are over 60)
BA 5 will increase the caseload substantially. Currently 68% of all cases in the country are BA 5 and that percentage is sure to grow.
So, if the most seriously affected by Covid are the elderly, and most of the elderly have conditions which preclude the use of Paxlovid, the use of another antiviral which can be used by all will be tremendous.
You state "Covid is horrible. But it is reality". So True
Why not just be able to deal with the reality and then everyone can rest
DD shows it finally IS Todos's time to takeoff, in my opinion
5/13/22 ...glad to see ZERO shares issued since last update
https://www.otcmarkets.com/stock/TOMDF/security
Agreed. We do not want to see any R/S..
Full Disclosure:. I AM a shareholder again
To correct post 9516 posted by someone else..... A 1/10,000 reverse split is not possible as share holders have approved that any R/S must be a minimum of 1/2 up to a maximum of 1/500.
Reference the Todos 8-K dated 7/27/2021.
Retire 43,
A simple yet crude analysis.
1 year ago (early May) I purchased my first shares here. There were approx 567M share outstanding at that time and the SP was approx .038....Market Cap 21.5 million.
Today approx 1.2 Billion shares at .012 SP yields a market cap of 14.3 million (33% reduction from a year ago).
Meanwhile last year Todos didn't own Provista, there was no 3CL Pharma merger, Tollovid Max and Daily sales were low, hardly much revenue, phase 2 study not complete and I could add much more.
In the world of pennies SP doesn't follow fundamentals often and is too often driven by hype, rumors etc but yes, I have to agree that either TODOS is extremely undervalued as you stated OR was extremely overvalued last year.
Drey,
I am not the most experienced but i will offer my take on some of your questions. I don't know why etrade doesn't show sub penny quotes. If the share price goes below 1 cent it will start at .0099 (99 one hundreths of a penny ) and can go as low as.0001 (1 one hundreth of a penny)
For instance look at AMBS. At this moment bid is .0045 ask is .0053 I dont know why etrade would not show this as I do not use it.
Many stocks when they go sub penny perform a large R/S to restore the share price to a respectable level. Problem is, in many cases, the price quickly resorts back down close to the pre-split price due to many factors, shorting being the main culprit.
I personally don't see TOMDF selling off any of its assets. I still feel their best option is to continue as is and hope to get an EUA or an OTC approval and a run in share price. Otherwise they will R/S OR R/S and uplist at the same time. (Both scary for current shareholders).
I bailed throughout March because I didn't like what I was seeing. Will monitor and possibly get back in and if I miss a big run-up so be it.
Maybe the presentation today will give some update to what is going on. I couldn't listen (at work)
I hope this answers some of your questions. Again I am NOT a current shareholder. All IMO and GLTA
Sword,
I went back and looked at my post 3490 which you reference. If my memory serves me, at about that time, there were many on this board that were discussing a possible R/S with an uplist and would it be possible to perform both simultaneously to avoid misery for shareholders.
My exact post was written on 9/15, the same day Todos issued a press release stating the 90 day lockup. In that press release was the following quote, "We believe this lockup agreement will provide confidence to the marketplace, give the Company sufficient room to complete certain strategic transactions currently being evaluated to unlock shareholder value and help facilitate the listing of our common shares on a national stock exchange in the months ahead.”
I felt at that time that the R/S could be imminent. Obviously it never occurred.
Presently, I see 90 days remaining until the R/S authorization expires. The expected rise in SP never happened and now sits at 1.25 cents. To me this points to the R/S occurring before the expiration date. GC stated numerous times that he would not perform one at such a low price and would try to reward his current shareholders.
So my only question was if he had re-iterated that stance recently as I was away from this board for awhile.
GLTA
Stu,
I remember he stated that numerous times and hopefully for all the longs here he will keep his word.
However, at this point, I think he has an out in that he can state that no matter what amount of good news was released, the share price did not respond as he anticipated, and his hands are tied at this point if he wants to get to the next level.
I go back to my question 3 posts ago. " Is GC still saying he will not be R/S ing this before the expiration date of the mid July authorization given by shareholders?" I've been away and am wondering if the topic has been tweeted about or discussed by him lately.
Again, not bashing, but if others see a different angle I would love to hear it as I still believe in the product, but see trouble for current shareholders with how it plays out.
AMHO
Stone,
Exactly correct. That is why I bailed as I don't see any other way to attract the investors other than R/S and uplist. And now it is down to approximately 90 days before the shareholder authorization to R/S expires.
That can greatly benefit those that wait until the R/S occurs, shorts rip it apart and the SP settles, and then buy in. But it screws everyone that has bought and held for so long, supporting the company throughout.
Too much risk for my blood to buy back in now.
I walked away from this exactly one month ago but still follow the story to some degree. Is GC still saying he will not be R/S ing this before the expiration date of the mid July authorization given by shareholders?
From an outsiders view that appears to be the only option left. 1.2 billion shares and a SP that can't gain any traction is a recipe for an R/S. The max 1/500 could still result in an uplist and finally attract the attention of some serious investors.
I am not bashing in any way. I actually think it is sad because I believe in the product but I think the hurdles Todos has to jump are insurmountable when a small company is cash poor and competing against the big boys.
Barring a buyout from big pharma I still see an R/S on the horizon and the shorts then running wild which will result in a nightmare for those holding.
And no, I won't be jealous if I am wrong and all longs hit it big. It will be a just reward for your patience (and courage).
GLTA
Does anyone think an endorsement by Billy Blanks deserves a press release.
99.9999 % of the world population have no idea who this guy is.
The 35 second you tube commercial had around 12 different angles at about 3 seconds each because I don't think the man could pronounce "3CL Protease Inhibitor" in one take.
This is part of the BIG NEWS that came out of all that pre-superbowl flag football hype?
TOTALLY RIDICULOUS!!!
JP,
Thanks for your input.
Made money on this ticker in 2021. Bought and have been holding from end of October till now so am down obviously in 2022.
Outstanding shares have doubled since March of last year yet there seems to be no slowing down (never a good sign)
Unlike others I appreciate posts by all, including you and Sapient, because it can cause some to hesitate and perform more of their own DD before they decide to invest.
And no, I won't be killed, as I never invest too much in any one issue.
Gonna wait and see what the financials show this week and if there is a lockup extension to maybe right this train before it totally falls off the tracks.
GLTA
JP. You state
IMHO Gerald Commissiong is a habitual serial diluter, con-artist, huckyster and master manipulator regarding both AMBS and TOMDF when on Twitter, in interviews, and on all other social media outlets protected by forward looking statements. Gerald knows how to use these platforms to his advantage - and to glean the attention of the unsuspecting or novice shareholder - by seperating them from their hard earned money...!
Please don't hold back.
How do you REALLY feel about GC
Velcro,
I stand corrected. I use the word "trips" to mean less than 1 penny.
I believe most people who trade in the pink stock world (of which I am not) refer to trips as trading below one tenth of a penny. Example CBDL trading at .0002/.0003.
Someone who trades there can tell you more accurately than me.
stu & velcro
Velcro
Toxic noteholders could take a long explanation. Read this link. It should help you.
"Trips" refers to when a share price falls below one cent. Example AMBS is trading at .0084 (84/100 of a penny)
https://pubcoceo.com/2017/10/16/toxic-debt-what-is-it-and-how-can-micro-cap-ceos-avoid-it/
Stu,
I hate to say it but JP may be the one who was right all along. This dilution is setting the stage for a massive R/S like he states. GC always stated that he would never do an R/S at these levels. Now with the massive dilution and no agreement with noteholders he has an "out" in which he can state that he had no choice but to perform the R/S. And a 1/500 will allow him to uplist before the expiration of the stockholders approval which is mid July if I remember right.
Still holding but not liking what I am seeing. Let's see what the annual financials look like this week.
Go ahead everyone. Bash away at me. But this is how I see it right now.
Still hoping for the Hail Mary here
Great news today but no real movement on share price.
IMO This ticker is in a tough spot right now. Looking at level II at this moment there are currently 3 million shares that can be bought at .0318 or less.
With over 1 billion shares outstanding, there are just too many people "playing" this for tenths of a penny. Buy at 2.6, sell at 3.0, taking their 15% gain.
Unfortunately, I feel that we are stuck in this hole until we get that first EUA. Maybe the quarterly that is coming out soon will start to move the SP due to anticipated increase in revenues.
Holding all my shares but this ride is going to take quite a while longer.
So, from the press release from Dec 13th is the following quote
"This New Lockup was entered into immediately after the expiry of a similar agreement on December 10, 2021 which was announced on September 24, 2021 (the “Old Lockup”)".
So the new agreement began at the EXACT MOMENT of the first expiration which was Friday December 10th.
So Friday March 11 (2 days ago) was EXACTLY 13 Fridays later. (13 weeks)
13 weeks at 7 days per week is 91 days.
So technically, the agreement is over.
Let's hope a new one has been inked and a press release will be out tomorrow.
GLTA
Oil,
A little confused by your response but here goes.
Noteholders bailing on this will be detrimental to the company and the shareholders. Flooding the market with shares will depress the share price even more; well below the current 3 cents. Note the 48 million shares already issued in the past few days.
There is no way current noteholders are happy. They have granted 2 extensions yet every bit of news has been met with steep resistance to share value.
Another extension is the only way this logically survives. If the PPS were to drop much more, the management will R/S this, even though they say they won't. Their desire is onefold... to get to a national exchange. This is the only way they will get recognition and attention from institutional investors.
As in every R/S, the current shareholders will suffer immensely but those who enter post R/S (after the shorts have their way) will prosper. Have seen this more times in my lifetime than I ever wanted
I seem to be the only person on this board who is a realist and wants to discuss the true ramifications of these actions.
I believe in the science, hold my shares long, would never invest more under these circumstances, yet meet resistance when I speak the truth.
Still GLTA of US
Lockup expiring in 2 days and 12 hours.
So far, not a peep from CEO.
I'm not sure how amenable these noteholders are going to be when they could've sold their shares at 7 to 8 cents three months ago and SP is now 2.8 cents.
Wondering what type of arm twisting is going on because I'm sure that, although GC stated they are in it for the long haul, their faith in their investment must be a little shaken, at the very least.
Are there any thoughts about this? Please share.
Closing of the deal will be great but at this close juncture I am more interested in hearing if there is another extension on the 90 day moratorium of the noteholders.
At the open of the market on Monday morning the 90 days will have expired.
Press release is a surprising setback for a company that has been so successful the past 31 years.
Gman a very good question which some others on this board, since deleted, misinterpreted.
It is frustrating when one sees companies that are worth billions, whose quarterly returns are extremely complex, file early or on time WHILE at the same time seeing TODOS, a 30 million market cap company, file toward the end of the alloted time.
A lot of it has to do with money, manpower and the ability to generate the quarterly report successfully.
For example, annual financials which must be audited and CPA approved, are much easier for billion dollar companies to file because they have the $$$$ to hire such firms as Deloitte, Ernst & Young, Price Waterhouse etc to do the work.
Smaller companies do not have that luxury and hire smaller, less populated firms, or hire a CPA who works alone.
Joe Forkeys post is very informative.
I agree that the sooner we can see improved revenues, the sooner we might get a pop in share price.
I hope this sheds even more light into your inquiry.
GLTA
Joe, You are correct.
I misread and thought GC was referring to the uplist when he was really talking about the possibility of Dr. Arad backing out when he said no.
I too remember that GC stated no R/S in that conference call unless SP improved dramatically. I remember years ago I had a CEO repeatedly swear no R/S only to have it happen a couple days later.
I guess I am still a little gunshy from that event.
Here's to GC keeping his word.
Thanks for that tweet, Joe.
If Nasdaq uplist is not on agenda for Q1 then neither is a R/S.
Now hopefully we can concentrate on positive press releases to raise awareness of Todos and Tollovir/vid to enhance the SP to a point which would make for a manageable R/S and uplist in the future.